World Desk, Amar Ujala, Washington
Printed by: Dev Kashyap
Up to date Fri, 17 Dec 2021 03:53 AM IST
The assembly of the CDC panel was convened by the Immunization Advisory Committee following an replace from the Meals and Drug Administration concerning the danger of uncommon however doubtlessly life-threatening blood clots related to the Johnson & Johnson vaccine. The committee voted unanimously to advocate Johnson & Johnson to not have the Kovid-19 vaccine.
Vaccine from Pfizer and Moderna (image picture)
– Photograph: PTI
hear the information
54 folks within the US endure from thrombocytopenia syndrome
The assembly of the CDC panel was convened by the Immunization Advisory Committee following an replace from the Meals and Drug Administration concerning the danger of uncommon however doubtlessly life-threatening blood clots related to the Johnson & Johnson vaccine. To this point, at the least 54 folks within the US, principally ladies, have been hospitalized after complaining of blood clots after taking the vaccine. Together with this, 9 folks have died.
Instances of thrombosis with thrombocytopenia syndrome (TTS) have been beforehand reported in folks taking Johnson & Johnson vaccine. Which entails blood clots with low ranges of platelets. The best reporting charges are amongst ladies beneath 50. The CDC stated the speed of such incidents in each ladies and men is greater than beforehand estimated.
The CDC’s Advisory Committee on Immunization voted unanimously to make the advice. Nevertheless, the regulator is but to log out on the rules. Panel members additionally stated that Johnson & Johnson’s vaccine is much less efficient in stopping COVID-19 than the opposite two licensed vaccines.
Johnson & Johnson’s scientist clarified
In a presentation to the advisory committee, a lead scientist at Johnson & Johnson stated the Johnson & Johnson vaccine produces a powerful and long-lasting immune response with only a single dose.
Dr. Penny Heaton of Johnson & Johnson stated within the presentation that “in conditions the place many individuals don’t return for a second dose or booster, the permanence of the single-shot Johnson & Johnson vaccine as a major dose continues within the US and around the globe.” Can play an vital position in saving lives.”
He defined that “Johnson & Johnson’s vaccine makes use of know-how based mostly on a modified model of the adenovirus to extend immunity in recipients, whereas the opposite two licensed vaccines use messenger RNA know-how.”